CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions to the fore and informing the patient community. This talk series will be hosted by Gary Petersen, our Myeloma talk...

While President Trump believes that  ‘slow and burdensome’  FDA drug approval process is ‘keeping too many new drugs from reaching the market’, former FDA Director Rob Califf differs in his opinion when he says that ‘Drug regulation drives innovation’. Rob Califf, a cardiologist goes on to...